Taiwan-developed rapid screening reagent put into trial production

A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)